MG
VTRS icon

Marex Group’s Viatris VTRS Stock Holding History

Marex Group’s Portfolio VTRS Stock Details VTRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$491K Buy
30,931
+5,337
+21% +$82.7K ﹤0.01% 705
2026
Q1 		$346K Sell
25,594
-206
-0.8% -$2.88K ﹤0.01% 730
2025
Q4 		$321K Buy
25,800
+12,351
+92% +$133K ﹤0.01% 688
2025
Q3 		$133K Hold
13,449
– – ﹤0.01% 760
2025
Q2 		$120K Sell
13,449
-23,255
-63% -$197K ﹤0.01% 555
2025
Q1 		$320K Buy
36,704
+15,657
+74% +$164K 0.01% 438
2024
Q4 		$262K Hold
21,047
– – ﹤0.01% 478
2024
Q3 		$244K Buy
21,047
+6,230
+42% +$71.9K 0.01% 429
2024
Q2 		$158K Sell
14,817
-18,688
-56% -$206K ﹤0.01% 534
2024
Q1 		$400K Sell
33,505
-7,928
-19% -$95.5K 0.01% 286
2023
Q4 		$449K Sell
41,433
-43,406
-51% -$416K 0.02% 324
2023
Q3 		$837K Buy
84,839
+903
+1% +$9.4K 0.12% 83
2023
Q2 		$838K Buy
83,936
+60,753
+262% +$580K 0.15% 97
2023
Q1 		$223K Buy
23,183
+6,344
+38% +$70.4K 0.03% 225
2022
Q4 		$187K Buy
+16,839
New +$176K 0.03% 236

Other funds holding VTRS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Marex Group's VTRS Position: Q2 2026 in Review

Marex Group increased its Viatris (VTRS) stake by 21% in Q2 2026, buying an estimated $82.7K and bringing the position to 30,931 shares worth $491K. The position accounts for ﹤0.01% of the portfolio, ranked #705.

Marex Group first reported a position in VTRS in Q4 2022 and has held it in 15 quarters since. The position peaked at $838K in Q2 2023. 1,028 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Marex Group held 30,931 shares of Viatris worth $491K as of Q2 2026.
  • Marex Group bought 5,337 Viatris shares in Q2 2026, an estimated $82.7K.
  • Viatris made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #705 holding.
  • Marex Group first reported a position in Viatris in Q4 2022 and has held it in 15 quarters since.
  • Marex Group's Viatris position peaked at $838K in Q2 2023.
  • 1,028 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.